Logo image of AMIX

AUTONOMIX MEDICAL INC (AMIX) Stock Fundamental Analysis

NASDAQ:AMIX - Nasdaq - US05330T2050 - Common Stock - Currency: USD

3.02  +0.09 (+3.07%)

Fundamental Rating

1

AMIX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. While AMIX seems to be doing ok healthwise, there are quite some concerns on its profitability. AMIX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AMIX had negative earnings in the past year.
In the past year AMIX has reported a negative cash flow from operations.
AMIX Yearly Net Income VS EBIT VS OCF VS FCFAMIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -5M -10M -15M

1.2 Ratios

AMIX's Return On Assets of -261.16% is on the low side compared to the rest of the industry. AMIX is outperformed by 95.74% of its industry peers.
AMIX has a worse Return On Equity (-463.24%) than 87.23% of its industry peers.
Industry RankSector Rank
ROA -261.16%
ROE -463.24%
ROIC N/A
ROA(3y)-339.93%
ROA(5y)N/A
ROE(3y)-388.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AMIX Yearly ROA, ROE, ROICAMIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -200 -400 -600

1.3 Margins

AMIX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMIX Yearly Profit, Operating, Gross MarginsAMIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for AMIX has been reduced compared to 1 year ago.
The debt/assets ratio for AMIX is higher compared to a year ago.
AMIX Yearly Shares OutstandingAMIX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M
AMIX Yearly Total Debt VS Total AssetsAMIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

Based on the Altman-Z score of -16.06, we must say that AMIX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -16.06, AMIX is not doing good in the industry: 85.11% of the companies in the same industry are doing better.
AMIX has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
AMIX has a Debt to Equity ratio (0.36) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z -16.06
ROIC/WACCN/A
WACCN/A
AMIX Yearly LT Debt VS Equity VS FCFAMIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 5M -5M

2.3 Liquidity

AMIX has a Current Ratio of 4.26. This indicates that AMIX is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 4.26, AMIX is doing good in the industry, outperforming 71.81% of the companies in the same industry.
AMIX has a Quick Ratio of 4.26. This indicates that AMIX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of AMIX (4.26) is better than 77.13% of its industry peers.
Industry RankSector Rank
Current Ratio 4.26
Quick Ratio 4.26
AMIX Yearly Current Assets VS Current LiabilitesAMIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M

More info and screens

1

3. Growth

3.1 Past

AMIX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18089.44%.
EPS 1Y (TTM)-18089.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-654.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 13.55% on average over the next years. This is quite good.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y53.89%
EPS Next 2Y15.2%
EPS Next 3Y13.55%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMIX Yearly Revenue VS EstimatesAMIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027
AMIX Yearly EPS VS EstimatesAMIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -2 -4 -6 -8 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMIX. In the last year negative earnings were reported.
Also next year AMIX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMIX Price Earnings VS Forward Price EarningsAMIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMIX Per share dataAMIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

AMIX's earnings are expected to grow with 13.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.2%
EPS Next 3Y13.55%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AMIX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AUTONOMIX MEDICAL INC

NASDAQ:AMIX (2/21/2025, 11:28:25 AM)

3.02

+0.09 (+3.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-13 2025-02-13/bmo
Earnings (Next)N/A N/A
Inst Owners0.4%
Inst Owner Change-29.51%
Ins Owners31.17%
Ins Owner Change0%
Market Cap5.35M
Analysts85.71
Price Target28.56 (845.7%)
Short Float %11%
Short Ratio0.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1900%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.77
P/tB 1.77
EV/EBITDA N/A
EPS(TTM)-14.01
EYN/A
EPS(NY)-11.02
Fwd EYN/A
FCF(TTM)-4.7
FCFYN/A
OCF(TTM)-4.68
OCFYN/A
SpS0
BVpS1.71
TBVpS1.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -261.16%
ROE -463.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-339.93%
ROA(5y)N/A
ROE(3y)-388.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.26
Quick Ratio 4.26
Altman-Z -16.06
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18089.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-654.71%
EPS Next Y53.89%
EPS Next 2Y15.2%
EPS Next 3Y13.55%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-504.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-259.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-258.5%
OCF growth 3YN/A
OCF growth 5YN/A